Education
About Us
Working with TipRanks
Follow Us
Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
LEGN Analyst Ratings
Strong Buy
12 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LEGN Stock 12 Month Forecast
Average Price Target
$83.27
▲(143.20% Upside)
| Highest Price Target$95.00 | Average Price Target$83.27 | Lowest Price Target$62.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
RBC Capital
Reiterated
04/22/25
Barclays
Reiterated
04/21/25
BMO Capital
Reiterated
04/16/25
H.C. Wainwright
Reiterated
04/16/25
BTIG
Reiterated
04/15/25
Jefferies
Reiterated
04/15/25
TD Cowen
Reiterated
04/10/25
Morgan Stanley
Reiterated
03/17/25
Citi
Reiterated
03/12/25
William Blair
Reiterated
03/12/25
Scotiabank
$76
Buy
121.96%
Upside
Reiterated
03/12/25
Analysts Offer Insights on Healthcare Companies: Legend Biotech (NASDAQ: LEGN), Oculis Holding (NASDAQ: OCS) and Meiragtx Holdings (NASDAQ: MGTX)
Truist Financial
―
Buy
―
Reiterated
03/12/25
Truist Financial Sticks to Its Buy Rating for Legend Biotech (LEGN)
Piper Sandler
$78
Buy
127.80%
Upside
Reiterated
03/12/25
Piper Sandler Reaffirms Their Buy Rating on Legend Biotech (LEGN)
Unknown Analyst
Not Ranked
Guggenheim
―
Hold
―
Reiterated
03/12/25
Goldman Sachs
$84.28
Buy
146.14%
Upside
Reiterated
01/22/25
Goldman Sachs reiterates Buy Rating on Legend Biotech Corp. (LEGN)Goldman Sachs analyst Ziyi Chen reiterated a Buy rating and $84.28 price target on Legend Biotech Corp. (NASDAQ: LEGN).
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
RBC Capital
Reiterated
04/22/25
Barclays
Reiterated
04/21/25
BMO Capital
Reiterated
04/16/25
H.C. Wainwright
Reiterated
04/16/25
BTIG
Reiterated
04/15/25
Jefferies
Reiterated
04/15/25
TD Cowen
Reiterated
04/10/25
Morgan Stanley
Reiterated
03/17/25
Citi
Reiterated
03/12/25
William Blair
Reiterated
03/12/25
Scotiabank
$76
Buy
121.96%
Upside
Reiterated
03/12/25
Analysts Offer Insights on Healthcare Companies: Legend Biotech (NASDAQ: LEGN), Oculis Holding (NASDAQ: OCS) and Meiragtx Holdings (NASDAQ: MGTX)
Truist Financial
―
Buy
―
Reiterated
03/12/25
Truist Financial Sticks to Its Buy Rating for Legend Biotech (LEGN)
Piper Sandler
$78
Buy
127.80%
Upside
Reiterated
03/12/25
Piper Sandler Reaffirms Their Buy Rating on Legend Biotech (LEGN)
Unknown Analyst
Not Ranked
Guggenheim
―
Hold
―
Reiterated
03/12/25
Goldman Sachs
$84.28
Buy
146.14%
Upside
Reiterated
01/22/25
Goldman Sachs reiterates Buy Rating on Legend Biotech Corp. (LEGN)Goldman Sachs analyst Ziyi Chen reiterated a Buy rating and $84.28 price target on Legend Biotech Corp. (NASDAQ: LEGN).
Best Analysts Covering Legend Biotech
Which Analyst Should I Follow If I Want to Buy LEGN and Sell After:
1 Month
xxx
Success Rate
8/14 ratings generated profit
Average Return
+1.15%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +1.15% per trade.
3 Months
xxx
Success Rate
6/14 ratings generated profit
Average Return
+0.51%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +0.51% per trade.
1 Year
Success Rate
6/14 ratings generated profit
Average Return
-8.27%
reiterated a buy rating 2 months ago
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -8.27% per trade.
2 Years
xxx
Success Rate
6/27 ratings generated profit
Average Return
-17.88%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -17.88% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LEGN Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
31
28
20
22
24
Buy
4
2
0
1
1
Hold
2
2
1
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
37
32
21
25
27
Each month's total comprises the sum of three months' worth of ratings.
LEGN Financial Forecast
LEGN Stock Forecast FAQ
What is LEGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Legend Biotech Corporation’s 12-month average price target is 83.27.
What is LEGN’s upside potential, based on the analysts’ average price target?
Legend Biotech Corporation has 143.20% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LEGN a Buy, Sell or Hold?
Legend Biotech Corporation has a consensus rating of Strong Buy which is based on 12 buy ratings, 2 hold ratings and 0 sell ratings.
What is Legend Biotech Corporation’s price target?
The average price target for Legend Biotech Corporation is 83.27. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $95.00 ,the lowest forecast is $62.00. The average price target represents 143.20% Increase from the current price of $34.24.
The highest analyst price target is $95.00 ,the lowest forecast is $62.00. The average price target represents 143.20% Increase from the current price of $34.24.
What do analysts say about Legend Biotech Corporation?
Legend Biotech Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of LEGN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.